Beats Medical

Beats Medical is a digital therapeutics company that focuses on central nervous system (CNS) and rare diseases. They provide digital assessments and therapeutics designed to empower patients in managing their symptoms independently. Their mission is to advance future therapies by delivering real results for insurers, pharmaceutical companies, and other healthcare stakeholders. The company offers a digital platform called Beats Medical Colbolt©, which enhances clinical research and drug development through precise, real-time data collection and analysis. This platform supports various phases of clinical trials, from pre-clinical stages to commercialization, and incorporates embedded digital biomarkers. Beats Medical's services include digital clinical research tools, symptom management apps, and data-driven insights aimed at improving healthcare outcomes. With a team of experts in health, pharma, and technology, Beats Medical is backed by the EU Horizon 2020 Programme and has received high ratings for regulatory approval and effectiveness. Their solutions are available in over 30 countries, with users collectively tracking 97 million steps through their technology.

• Employees 19
• Founded 2012